Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatic analysis of potential biomarkers and mechanisms of immune infiltration in mitral regurgitation complicated by atrial fibrillation. | Ann Transl Med | 2022 | 36467340 | PubTator, text mining | PubMed |
| The diagnostic potential of novel biomarkers of hypertension in men. | Arch Med Sci | 2022 | 36457990 | PubTator, text mining | PubMed |
| A Narrative Review of the Pathophysiology and Treatment of Hypertrophic Cardiomyopathy. | South Med J | 2022 | 36455903 | PubTator, text mining | PubMed |
| Case Report: Novel LIM domain-binding protein 3 (LDB3) mutations associated with hypertrophic cardiomyopathy family. | Front Pediatr | 2022 | 36452351 | PubTator, text mining | PubMed |
| First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy. | Front Cardiovasc Med | 2022 | 36440055 | PubTator, text mining | PubMed |
| Case report: Rare restrictive cardiomyopathy with ventricular fibrillation as initial symptom rescued by automatic external defibrillator in a pediatric patient. | Front Cardiovasc Med | 2022 | 36440023 | PubTator, text mining | PubMed |
| Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research. | J Pers Med | 2022 | 36422086 | PubTator, text mining | PubMed |
| AKAP9-Related Channelopathy: Novel Pathogenic Variant and Review of the Literature. | Genes (Basel) | 2022 | 36421840 | PubTator, text mining | PubMed |
| Defining the S-Glutathionylation Proteome by Biochemical and Mass Spectrometric Approaches. | Antioxidants (Basel) | 2022 | 36421458 | PubTator, text mining | PubMed |
| Disruption of cardio-pulmonary coupling in myopathies: Pathophysiological and mechanistic characterization with special emphasis on nemaline myopathy. | Front Cardiovasc Med | 2022 | 36419493 | PubTator, text mining | PubMed |
| Sudden Cardiac Arrest in Athletes: A Primary Level of Prevention. | Cureus | 2022 | 36415444 | PubTator, text mining | PubMed |
| Isolated Left Ventricular Noncompaction Presenting With Heart Failure With Reduced Ejection Fraction and Intrahospital Cardiac Arrest: A Case Report and Literature Review. | Cureus | 2022 | 36415422 | PubTator, text mining | PubMed |
| Heart Failure Pathogenesis Elucidation and New Treatment Method Development. | JMA J | 2022 | 36407067 | PubTator, text mining | PubMed |
| Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy and the impact of mavacamten. | Ther Adv Chronic Dis | 2022 | 36407022 | PubTator, text mining | PubMed |
| Generation of a new human induced pluripotent stem cell (hiPSC) line from a South Asian Indian with a MYBPC3Δ25bp variant. | Stem Cell Res | 2022 | 36403549 | PubTator, text mining | PubMed |
| The mechanical cell - the role of force dependencies in synchronising protein interaction networks. | J Cell Sci | 2022 | 36398718 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy secondary to tacrolimus therapy in a kidney transplant patient: A case report and focused review of the literature. | Clin Case Rep | 2022 | 36397856 | PubTator, text mining | PubMed |
| Recurrent acute myocarditis: An under-recognized clinical entity associated with the later diagnosis of a genetic arrhythmogenic cardiomyopathy. | Front Cardiovasc Med | 2022 | 36386348 | PubTator, text mining | PubMed |
| Genetics and clinics: together to diagnose cardiomyopathies. | Eur Heart J Suppl | 2022 | 36380800 | PubTator, text mining | PubMed |
| Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study. | PLoS One | 2022 | 36378654 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=37